EMCDDA. New EMCDDA report highlights greater diversity of cannabis products, increasing potency and the need for close monitoring of health effects
EMCDDA. New EMCDDA report highlights greater diversity of cannabis products, increasing potency and the need for close monitoring of health effects
Cannabis products have become increasingly diverse in Europe and close monitoring of their potency and potential health effects is essential. These are among the conclusions of a new report published today by the EU drugs agency (EMCDDA) ahead of International day against drug abuse and illicit trafficking (26 June) (1). The report — Developments in the European cannabis market (2) — provides an overview of emerging and established cannabis products in Europe. (EMCDDA, Lissabon 25.06.2019 (News release No 5/2019))
http://www.emcdda.europa.eu/news/2019/5/developments-in-the-european-cannabis-market_en